OverviewChartNewsTraderScreen

BNP Paribas Discount Zert BMY 26..../  DE000PC4GWJ2  /

Frankfurt Zert./BNP
10/11/2024  9:40:16 PM Chg.-0.070 Bid9:59:57 PM Ask9:59:57 PM Underlying Strike price Expiration date Option type
38.610EUR -0.18% 38.660
Bid Size: 6,000		 38.710
Ask Size: 6,000		 Bristol Myers Squibb... - USD 6/26/2025 Call
GlobeNewswire 9/3 Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer
GlobeNewswire 9/2 CSE Announces its 2024 Sustainability & ESG Leadership Summit at NYC's One World Trade Center
GlobeNewswire 8/30 Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment Conference
GlobeNewswire 8/29 Immunocore announces transition of Chief Financial Officer
GlobeNewswire 8/28 Hematologists Highlight Ongoing Challenges in Sickle Cell Disease and Thalassemia Amidst Promising A...
GlobeNewswire 8/22 Abata Therapeutics Receives FDA Fast Track Designation for ABA-101 for the Treatment of Progressive ...
GlobeNewswire 8/15 Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement o...
GlobeNewswire 8/12 Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in C...
Newsfile Corp 8/12 The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
GlobeNewswire 8/12 Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer
GlobeNewswire 8/8 CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 8/7 Efficacy and Safety Data of Sotagliflozin in Patients with Type 1 Diabetes and Chronic Kidney Diseas...
GlobeNewswire 8/6 ALX Oncology Appoints Alan Sandler, M.D., to Board of Directors
GlobeNewswire 8/5 iTeos Therapeutics Announces Appointment of David Feltquate as Chief Medical Officer
GlobeNewswire 8/1 Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies i...
GlobeNewswire 8/1 CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024
GlobeNewswire 7/31 Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Boar...
GlobeNewswire 7/30 Anaveon appoints Dieter Weinand as Chair of its Board of Directors
GlobeNewswire 7/25 Purple Biotech Receives Extension to Regain Compliance with the Nasdaq’s Minimum Bid Price Rule
GlobeNewswire 7/24 Prota Therapeutics Strengthens Board with Appointment of Global Biotech Expert Patrick Machado
GlobeNewswire 7/20 NCLA Asks Third Circuit to Rule Against HHS’s Coercive Medicare Drug Price ‘Negotiation’ Program
GlobeNewswire 7/17 Nouscom Appoints Tiffany Muller as Chief Financial Officer and Loredana Siani as Senior Vice Preside...
GlobeNewswire 7/9 VYNE Therapeutics Announces Appointment of Subhashis Banerjee, M.D. as Senior Vice President of Clin...
GlobeNewswire 7/9 Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors
GlobeNewswire 7/8 Lexeo Therapeutics Appoints Tim Van Hauwermeiren to its Board of Directors